| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $61.9M | +10.2% |
| Cost of Revenue | $20.9M | +0.2% |
| R&D Expense | $480K | -95.1% |
| SG&A Expense | $44.4M | +10.4% |
| Operating Income | -$8.2M | +40.3% |
| Interest Expense | $3.7M | +37.0% |
| Pre-tax Income | -$11.4M | +22.2% |
| Income Tax | $60K | -1.6% |
| Net Income | -$11.4M | +22.1% |
| EPS (Basic) | -$0.47 | +34.7% |
| EPS (Diluted) | -$0.47 | +34.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $24.1M | +18.6% |
| Accounts Receivable | $29.8M | +191.1% |
| Inventory | $9.6M | -33.3% |
| Current Assets | $66.9M | +38.8% |
| Total Assets | $94.6M | +17.9% |
| Current Liabilities | $37.4M | +6.4% |
| Long-term Debt | $25.3M | +1.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | -36.3% |
| Investing Cash Flow | -$15.0M | +0.0% |
| Financing Cash Flow | $16.2M | -4.5% |
| $62.7M |
| +4.3% |
| Stockholders' Equity | $31.9M | +58.7% |